Actinomycin D synergistically enhances the efficacy of the BH3 mimetic ABT-737 by downregulating Mcl-1 expression
Authors:
- 1 November 2010
- journal article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 10 (9) , 918-929
Abstract
Many types of cancer cells possess the ability to evade apoptosis, leading to their rapid and uncontrolled proliferation. As major regulators of apoptosis, Bcl-2 proteins serve as emerging targets ...Keywords
This publication has 53 references indexed in Scilit:
- Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosisCell Death & Differentiation, 2010
- SnapShot: BCL-2 ProteinsCell, 2009
- Execution of Superoxide-Induced Cell Death by the Proapoptotic Bcl-2-Related Proteins Bid and BakMolecular and Cellular Biology, 2009
- Chemotherapy Induces Tumor Clearance Independent of ApoptosisCancer Research, 2008
- BH3 Mimetic ABT-737 Potentiates TRAIL-Mediated Apoptotic Signaling by Unsequestering Bim and Bak in Human Pancreatic Cancer CellsCancer Research, 2008
- How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?Trends in Cell Biology, 2008
- Bcl-2-regulated apoptosis: mechanism and therapeutic potentialCurrent Opinion in Immunology, 2007
- Bak and Bax are non‐redundant during infection‐ and DNA damage‐induced apoptosisThe EMBO Journal, 2007
- Promoting apoptosis as a strategy for cancer drug discoveryNature Reviews Cancer, 2005
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001